$0.097
-0.010 (-10.19%)收盤時
- High
- 0.105
- Open
- 0.090
- VWAP
- 0.10
- Vol
- 29.61M
- Mkt Cap
- 29.31M
- Low
- 0.085
- Amount
- 2.83M
- EV/EBITDA, TTM
- -6.64
Cutera, Inc. develops, manufactures, distributes, and markets energy-based product platforms for medical practitioners, enabling them to offer treatments to their customers. The Company distributes third-party manufactured skincare products and secret systems and consumables. Its system platforms include AviClear, enlighten, excel, truSculpt, Secret PRO, Secret RF, and xeo. The Company’s Cutera Core segment consists of the Company’s systems, consumables, skincare, and service businesses. The Cutera Core segment develops, distributes and manufactures energy-based systems for medical practitioners in addition to distributing third-party manufactured skincare products in Japan. The Company’s AviClear segment consists of the AviClear business. The Company’s acne solution, AviClear, is a prescription-free, drug-free laser treatment for the treatment of mild to severe acne. Its products include CUTERA, ACUTIP 500, AVITM, AVI360, AVIANALYTICSTM, AVICARE COOLGLIDE, and more.
Analyst Ratings (4)
Piper Sandler
$1
2024-08-09
Piper Sandler
2024-08-09
目標價
$1
Stephens & Co.
$5
2024-08-09
Stephens & Co.
2024-08-09
目標價
$5
Stephens & Co.
$10
2024-06-25
Stephens & Co.
2024-06-25
目標價
$10
Piper Sandler
$3
2024-06-21
Piper Sandler
2024-06-21
目標價
$3
William Blair
—
2024-03-22
William Blair
2024-03-22
目標價
—
估值指標
事件時間軸
資訊
9.005-01NewsfilterCutera® Successfully Completes Restructuring Transaction and Moves Forward with Enhanced Capital Structure
4.503-11BenzingaUS Stocks Mixed; Kohl's Shares Plunge After Q4 Results
9.503-11BenzingaWhy Paymentus Holdings Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
7.003-11NASDAQ.COMCutera Announces Voluntary Delisting From Nasdaq
- 2.003-10Newsfilter
Cutera Announces Voluntarily Delisting from Nasdaq
CUTR FAQ — answered by Alphio AI
Cutera, Inc. develops, manufactures, distributes, and markets energy-based product platforms for medical practitioners, enabling them to offer treatments to their customers. The Company distributes third-party manufactured skincare products and secret systems and consumables. Its system platforms include AviClear, enlighten, excel, truSculpt, Secret PRO, Secret RF, and xeo. The Company’s Cutera Core segment consists of the Company’s systems, consumables, skincare, and service businesses. The Cutera Core segment develops, distributes and manufactures energy-based systems for medical practitioners in addition to distributing third-party manufactured skincare products in Japan. The Company’s AviClear segment consists of the AviClear business. The Company’s acne solution, AviClear, is a prescription-free, drug-free laser treatment for the treatment of mild to severe acne. Its products include CUTERA, ACUTIP 500, AVITM, AVI360, AVIANALYTICSTM, AVICARE COOLGLIDE, and more. It operates in the Healthcare sector (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry).
4 analysts cover CUTR: 3 rate it Buy, 1 Hold and 0 Sell.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。